0924 GMT November 20, 2019
More attention is required to be paid to domestic products in the medical sector, said the speaker of the Iranian Parliament in Tehran on Saturday.
Ali Larijani added this is because in the near future most European firms may refrain from cooperating with Iranian companies due to the reimposition of unilateral US sanctions, IRNA wrote.
In May, US President Donald Trump announced Washington’s withdrawal from the Joint Comprehensive Plan of Action (JCPOA), signed between Iran and P5+1 in July 2015, and said the White House will unilaterally reimpose nuclear sanctions on Iran.
Since then, the remaining signatories to the JCPOA, including Iran as well as Germany, France, the UK, China and Russia, began talks on ways to preserve the deal and safeguard Tehran’s interests within the framework of the international agreement.
“Perhaps in case Iran’s talks with Europe produces favorable results, small European firms would collaborate with us. But [most] probably the large ones will not,” Larijani pointed out.
Lauding the performance and the sense of responsibility of all those involved in Iran’s health system and medical sector following the victory of Iran’s 1979 Islamic Revolution, he said calibrated and thoughtful plans have been drawn up in this sector.
Describing the number of physicians and quality of medical services in Iran as insufficient and poor prior to the victory of the Islamic Revolution, Larijani noted that the Islamic Revolution has helped those involved in Iran’s medical sector effectively organize health and medical services in the country very well.
Commenting on US sanctions and their impacts on Iran’s health and medical sector, he said the Iranian government and Parliament will do their best to relieve the pressure posed by the sanctions on the people.
Parliament speaker added, “No doubt Iran possesses enhanced capabilities to overcome the present circumstances. For instance, the ground is prepared and the potential exists in [domestic] medical sector for further growth. Some 97 percent of the pharmaceuticals consumed by Iranians are produced domestically.”
He urged that the same percentage of self-sufficiency is required in the production of medical devices.
The Iranian Parliament will continue supporting Iran’s Health Sector Evolution Plan in the year to mid-March 2019, Larijani underlined.
In 2014, a series of reforms, called as the Health Sector Evolution Plan, was launched in the health system of Iran in a step-by-step manner.